Lidocaine block of LQT-3 mutant human Na+ channels

Circulation Research

Volumn 79, Issue 1, 1996, Pages 103-108

  An, R H ^a   Bangalore, R ^a   Rosero, S Z ^a   Kass, R S ^a,b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b The New York Presbyterian Hospital   (United States)

Author keywords

congenital heart disease; lidocaine; long QT syndrome; molecular genetics

Indexed keywords

LIDOCAINE; SODIUM CHANNEL;

ARTICLE; DELETION MUTANT; DRUG EFFECT; HUMAN; HUMAN CELL; LONG QT SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SLOW INWARD CURRENT; SODIUM CURRENT; TRANSPORT KINETICS;

EID: 0029931372     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.1.103     Document Type: Article

References (35)

1. Moss AJ, Robinson J. Clinical features of the idiopathic long QT syndrome. Circulation. 1992;85(suppl I):I-140-I-144.
2. Moss AJ, Robinson JL. The long-QT syndrome: genetic considerations. Trends Cardiovasc Med. 1993;2:81-83.
3. Keating M, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science. 1991;252:704-706.
4. Keating M, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Evidence of genetic heterogeneity in the long QT syndrome. Science. 1993;260:1960-1961.
5. Keating M. Genetics of the long QT syndrome. J Cardiovasc Electrophysiol. 1994;5:146-153.
6. Schott JJ, Charpentier F, Peltier S, Foley P, Drouin E, Bouhour JB, Donnelly P, Vergnaud G, Bachner L, Moisan JP, Lemarec H, Pascal O. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet. 1995;57:1114-1122.
7. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795-803.
8. Kr potassium channel. Cell. 1995;81:299-307.
9. Trudeau MC, Warmke JW, Ganetzky B, Robertson GA. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science. 1995;269:92-95.
10. Warmke JW, Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci U S A. 1994;91:3438-3442.
11. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80: 805-811.
12. Catterall WA. Structure and function of voltage-gated ion channels. Trends Neurosci. 1993;16:500-506.
13. Kass RS. Ionic basis of electrical activity in the heart. In: Sperelakis N, ed. Physiology and Pathophysiology of the Heart. 3rd ed. Norwell, Mass: Kluwer Academic Publishers; 1994.
14. Attwell D, Cohen I, Eisner D, Ohba M, Ojeda C. The steady state TTX-sensitive ('window') sodium current in cardiac Purkinje fibres. Pflugers Arch. 1979;379:137-142.
15. Catterall W, Epstein PN. Ion channels. Diabetologia. 1992;35(suppl 2):S23-S33.
16. Catterall WA, Trainer V, Baden DG. Molecular properties of the sodium channel: a receptor for multiple neurotoxins. Bull Soc Pathol Exot. 1992;85:481-485.
17. Stuhmer W, Conti F, Suzuki H, Wang X, Noda M, Yahagi N, Kubo H, Numa S. Structural parts involved in activation and inactivation of the sodium channel. Nature. 1989;339:597-603.
18. Noda M, Suzuki H, Numa S, Stuhmer W. A single point mutation confers tetrodotoxin and saxitoxin insensitivity on the sodium channel II. FEBS Lett. 1989;259:213-216.
19. Suzuki H, Beckh S, Kubo H, Yahagi N, Ishida H, Kayano T, Noda M, Numa S. Functional expression of cloned cDNA encoding sodium channel III. FEBS Lett. 1988;228:195-200.
20. Vassilev P, Scheuer T, Catterall WA. Inhibition of inactivation of single sodium channels by a site-directed antibody. Proc Natl Acad Sci U S A. 1989;86:8147-8151.
21. West JW, Patton DE, Scheuer T, Wang Y, Goldin AL, Catterall WA. A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation. Proc Natl Acad Sci U S A. 1992;89:10910-10914.
22. Bennett PB, Yazawa K, Makita N, George AL. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376:683-685.
23. Hondeghem LM, Katzung BG. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta. 1977;472:373-398.
24. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol. 1977;69:497-515.
25. Starmer CF, Courtney KR. Modeling ion channel blockade at guarded binding sites: application to tertiary drugs. Am J Physiol. 1986;251:H848-H856.
26. Cahalan MD, Almers W. Interactions between quaternary lidocaine, the sodium channel gates, and tetrodotoxin. Biophys J. 1979;27: 39-55.
27. Strichartz G. Effects of tertiary local anesthetics and their quaternary derivatives on sodium channels of nerve membranes. Biophys J. 1977;18:353-354.
28. McPhee JC, Ragsdale DS, Scheuer T, Catterall WA. A mutation in segment IVS6 disrupts fast inactivation of sodium channels. Proc Natl Acad Sci U S A. 1994;91:12346-12350.
29. Ragsdale DS, McPhee JC, Scheuer T, Catterall WA. Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science. 1994;265:1724-1728.
30. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391: 85-100.
31. + channel protein in mammalian cells and immunolocalization in guinea pig heart. Circ Res. 1993;73:968-973.
32. Weidmann S. Effect of current flow on the membrane potential of cardiac muscle. J Physiol. 1951;115:227-236.
33. Moss AJ, Zareba W, Benhorin J, Locati EH, Hall WJ, Robinson JL, Schwartz PJ, Towbin JA, Vincent GM, Lehmann MH, Keating MT, MacCluer JW, Timothy KW. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 1995;92:2929-2934.
34. Bean BP, Cohen CJ, Tsien RW. Lidocaine block of cardiac sodium channels. J Gen Physiol. 1983;81:613-642.
35. McEvoy GK. Lidocaine hydrochloride. In: McEvoy GK, ed. American Hospital Formulary Service: Drug Information 95. Bethesda, Md: American Society of Health System Pharmacists; 1995: 1102-1105.